The costs of longer-length scripts

Anthony Tassone refutes recent claims around longer-length prescriptions, and looks at their drawbacks A recent article in the Medical Journal of Australia, written by Dr Evan Ackermann, cannot go unchallenged for its disingenuous approach to patient care. Under the suitably emotive headline of Exorbitant costs of routine medication repeats, Dr Ackermann seeks to build an